Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pituitary gland

New consensus in acromegaly: criteria for cure and control

Nature Reviews Endocrinology volume 6, pages 480–481 (2010)Cite this article

Subjects

Developments in treatment modalities and assays over the past 10 years warranted a new consensus on the criteria for cure of acromegaly, which was reached at a meeting of the Acromegaly Consensus Group, in April 2009. The novel consensus statement highlights current analytical pitfalls and the need to optimize disease control in acromegaly.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Melmed, S. Medical progress: Acromegaly. N. Engl. J. Med. 355, 2558–2573 (2006).

    Article  CAS  Google Scholar 

  2. Giustina, A. et al. Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000).

    CAS  PubMed  Google Scholar 

  3. Giustina, A. et al. A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. doi:10.1210/jc.2009-2670.

  4. Trainer, P. J. et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N. Engl. J. Med. 342, 1171–1177 (2000).

    Article  CAS  Google Scholar 

  5. Feenstra, J. et al. Combined therapy with somatostatin analogs and weekly pegvisomant in active acromegaly. Lancet 365, 1644–1646 (2005).

    Article  CAS  Google Scholar 

  6. Freda, P. U. et al. Long-acting somatostatin analog therapy of acromegaly: A meta-analysis. J. Clin. Endocrinol. Metab. 90, 4465–4473 (2005).

    Article  CAS  Google Scholar 

  7. Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Romijn, J. A. & Vandenbroucke, J. P. Mortality in acromegaly: a meta-analysis. J. Clin. Endocrinol. Metab. 93, 61–67 (2008).

    Article  CAS  Google Scholar 

  8. Bex, M. et al. AcroBel—the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects. Eur. J. Endocrinol. 157, 399–409 (2007).

    Article  CAS  Google Scholar 

  9. Mestron, A. et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur. J. Endocrinol. 151, 439–446 (2004).

    Article  CAS  Google Scholar 

  10. Atkins, D. et al. Grading quality of evidence and strength of recommendations. BMJ 328, 1490 (2004).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333, ZA, The Netherlands

    Nienke Biermasz

Authors
  1. Nienke Biermasz
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biermasz, N. New consensus in acromegaly: criteria for cure and control. Nat Rev Endocrinol 6, 480–481 (2010). https://doi.org/10.1038/nrendo.2010.129

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2010.129

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing